Vimarsana
Biggest News Aggregation in the World

Preterm Risk News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Preterm Risk. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Preterm Risk Today - Breaking & Trending Today

Sera Prognostics Announces Positive Top-line Data from AVERT PRETERM TRIAL - Vimarsana News

Sera Prognostics Announces Positive Top-line Data from AVERT PRETERM TRIAL

Published: February 15, 2023

/PRNewswire/ -- Sera Prognostics Inc., The Pregnancy Company® (NASDAQ: SERA), focused on improving maternal and neonatal health by providing innovative...

Source: prnewswire.com
Related Topics:
United StatesSalt Lake CityGregoryc CritchfieldPeter DenardoExchange Commission OnSera Prognostics IncPrnewswire Sera Prognostics IncPregnancy CompanyPrognostics IncSerum AssessmentPreterm Birth Outcomes ComparedHistorical ControlsProteomic AssessmentPreterm RiskMulticenter AssessmentSpontaneous Preterm Birth Risk PredictorSera PrognosticsDimes Report CardPrivate Securities Litigation Reform ActFinal ProspectusExchange CommissionQuarterly ReportsAnnual ReportsCurrent Reports
FORS MARSH TO INCLUDE THE PreTRM® TEST IN ITS EMPLOYEE MATERNITY BENEFITS PACKAGE IN COLLABORATION WITH SERA PROGNOSTICS - Vimarsana News

FORS MARSH TO INCLUDE THE PreTRM® TEST IN ITS EMPLOYEE MATERNITY BENEFITS PACKAGE IN COLLABORATION WITH SERA PROGNOSTICS

Published: November 29, 2022

/PRNewswire/ -- Sera Prognostics Inc., The Pregnancy Company® (NASDAQ: SERA), focused on improving maternal and neonatal health by providing innovative...

Source: prnewswire.com
Related Topics:
United StatesSalt Lake CityPrnewswire SeraGregoryc CritchfieldSera PreChristina DaughertyErich SandovalFors Marsh GroupSera Prognostics IncPregnancy CompanyFors MarshFors Marsh PeopleCulture Director ChristinaProteomic AssessmentPreterm RiskPreterm BirthMedical EconomicsDimes Report CardSera PrognosticsPrivate SecuritiesFinal ProspectusAnnual ReportsCurrent ReportsHuman Resource Amp Workforce ManagementPublishing Amp Information Services
SONRAVA HEALTH TO INCLUDE THE PreTRM® TEST IN ITS EMPLOYEE MATERNITY BENEFITS PACKAGE IN COLLABORATION WITH CEREBRAE AND SERA PROGNOSTICS - Vimarsana News

SONRAVA HEALTH TO INCLUDE THE PreTRM® TEST IN ITS EMPLOYEE MATERNITY BENEFITS PACKAGE IN COLLABORATION WITH CEREBRAE AND SERA PROGNOSTICS

Published: October 4, 2022

/PRNewswire/ -- Sera Prognostics Inc., The Pregnancy Company® (NASDAQ: SERA), focused on improving maternal and neonatal health by providing innovative...

Source: prnewswire.com
Related Topics:
United StatesSalt Lake CityGregoryc CritchfieldSera PreErich SandovalKevin SimesFrank CheungExchange Commission OnSera Prognostics IncLooksbrite Eye CentersPrnewswire Sera Prognostics IncSonrava HealthPregnancy CompanyPrognostics IncCerebrae PlatformTotal RewardsWestern DentalChief Executive OfficerProteomic AssessmentPreterm RiskMulticenter AssessmentSpontaneous Preterm Birth Risk PredictorBrident DentalMid Atlantic Dental PartnersPerfect Teeth
BANNER HEALTH, SERA PROGNOSTICS TEAM UP TO PROVIDE PreTRM® TEST TO COVERED PREGNANT MEMBERS - Vimarsana News

BANNER HEALTH, SERA PROGNOSTICS TEAM UP TO PROVIDE PreTRM® TEST TO COVERED PREGNANT MEMBERS

Published: September 22, 2022

/PRNewswire/ -- Sera Prognostics Inc., The Pregnancy Company® (NASDAQ: SERA), focused on improving maternal and neonatal health by providing innovative...

Source: prnewswire.com
Related Topics:
United StatesSalt Lake CityGregoryc CritchfieldSera PrePeter DenardoErich SandovalRobert KraussExchange Commission OnSera Prognostics IncPrnewswire Sera Prognostics IncBanner HealthPregnancy CompanyUniversity Health PlansUniversity Family CareBanner Md Anderson Cancer CenterUniversity HealthUniversity MedicinePrognostics IncUniversity FamilyOutcomes ResearchMedical DirectorProteomic AssessmentPreterm RiskMulticenter AssessmentSpontaneous Preterm Birth Risk Predictor
Sera Prognostics: Chance To Become Standard In Preterm Birth Risk Screening - Vimarsana News

Sera Prognostics: Chance To Become Standard In Preterm Birth Risk Screening

Published: August 10, 2022

SERA sells PreTRM, a CLIA-lab based assay to determine the risk of a woman having a pre-term birth – a birth prior to 37 weeks of gestation. Read more here.

Source: seekingalpha.com
Related Topics:
United StatesSalt Lake CityBenjamin JacksonJay BonifaceGreg CritchfieldSera PreAslan AlphanKaiser PermanenteJay MoyesElevance HealthIntermountain Health SystemOutcomes ResearchManagement TeamLife Science Opportunity FundClinical Laboratory Improvement AmendmentProteomic AssessmentPreterm RiskMulticenter AssessmentSpontaneous Preterm Birth PredictorMeier CurveMeier CurvesPrognostics Stock ChartGeneral CounselMyriad GeneticsGenetics Stock Chart